Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0001193125-26-412654

Options or other derivatives

  • Director acquired 2,189 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Manning Paul B · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-30 Grant or award : show line 1 in the form Stock Option (Right to Buy) +2,189 $8.68 $18,992 2,189 D
Loading xslF345X06/ownership.xml…